UK shares: should I buy CareTech Holding following this news?

The CareTech Holding share price has fallen despite the release of robust first-half results. Should I buy this UK healthcare share for my portfolio?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The CareTech Holding (LSE: CTH) share price has slipped on Thursday following the release of the company’s half-year financials. 

Over the past 12 months, the CareTech share price is up 44%. But the AIM-listed company has reversed 1% today, to 603p per share, and away from Wednesday’s 14-year closing high of 610p. I think this mild retracement reflects light bouts of profit-taking rather than investor disappointment at the latest numbers.

Sales and profits power higher

In its interim report, CareTech said that revenues soared 16.5% during the six months to March, to £243m. This helped push underlying earnings before interest, taxes, depreciation, and amortisation (EBITDA) 19.1% higher year-on-year to £49.4m.

The UK healthcare share — which provides residential care for children, young people, and adults with special requirements — said that organic sales rose during the first half. It added that the transfer of adult specialist services sites from The Huntercombe Group, constructive fee negotiations, and the positive impact of Smartbox Assistive Technology also contributed to the year-on-year increase.

CareTech acquired Smartbox, which manufactures software and hardware that allow people with speech problems to communicate, last October.

Dividends hiked

In other news, CareTech saw net debt edge down to £263.1m as of March from £268.9m six months earlier. This helped reduce its net debt to adjusted EBITDA ratio to fall to 2.8 times from 3.1 times at the end of financial 2020.

Finally, CareTech pledged to pay a half-time dividend of 4.6p per share following its strong first-half performance. That marks a 15% improvement from the 4p interim payment shelled out last year.

Executive chair Farouq Sheikh said, “The group’s first half performance has been strong with all operational divisions demonstrating considerable resilience… Covid-19 has highlighted the importance of having community based, high quality social care facilities to relieve the pressures on the NHS”.

He added, “We remain confident of our outlook, delivering further earnings and dividend growth and in the long-term prospects of the business.”

Why I’d buy CareTech shares

City analysts seem to be in agreement that CareTech will keep enjoying solid progress on these fronts, too. Indeed, annual profits are tipped to rise 8% and 9% in financial 2021 and 2022 respectively. This leaves the company trading on a forward price-to-earnings (P/E) ratio of just 13 times. Of course, forecasts can change based on future developments. 

But I think this valuation is far too low given CareTech’s terrific defensive qualities. Its operations remain stable during economic upturns and downturns. And what’s more, it is a market leader in a growing sector. Government forecasts suggest the number of adults requiring social care between 18 and 64 years of age will rise 29% between 2018 and 2038, for example.

Okay, firms with large appetites for M&A like CareTech can take a hit if acquisitions disappoint. This particular UK healthcare share is also vulnerable to potential changes in healthcare investment at the government level. But all things considered I still think this AIM firm is a top stock to buy for my portfolio right now.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Should I still be cautious about Rolls-Royce shares?

Rolls-Royce shares are flying. But is now the time for this Fool to open a position? Here, he explains why…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

Is the Diageo share price coiled to rebound?

Christopher Ruane explains why he remains bullish about the long-term outlook for the Diageo share price and would happily invest…

Read more »

Young Asian woman holding a cup of takeaway coffee and folders containing paperwork, on her way into the office
Investing Articles

How I could make a 10% yield for high passive income a reality

Jon Smith explains how he can target high passive income from top-yielding stocks, including one specific example he'd consider.

Read more »

Investing Articles

I’d buy 1,784 shares of this FTSE 100 stock to target £350 of monthly passive income

Muhammad Cheema takes a look at how British American Tobacco shares, with a dividend yield of 10.1%, can generate a…

Read more »

White female supervisor working at an oil rig
Investing Articles

1 ex-FTSE 100 stock that I think will get promoted soon

Jon Smith flags up an energy stock that used to be in the FTSE 100 and currently has strong momentum…

Read more »

Shot of a young Black woman doing some paperwork in a modern office
Investing Articles

With an 8% dividend yield, I think this undervalued FTSE stock is a no-brainer buy

With an impressive yield and good track record of payments, Mark David Hartley is considering adding this promising FTSE share…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

£9,500 in savings? Here’s how I’d try to turn that into £1,809 a month of passive income

Investing a relatively small amount into high-yielding stocks and reinvesting the dividends paid can generate significant passive income over time.

Read more »

Businesswoman analyses profitability of working company with digital virtual screen
Investing Articles

Dividend star Legal & General’s share price is still marked down, so should I buy more?

Legal & General’s share price looks very undervalued against its peers. But it pays an 8%+ dividend yield, and has…

Read more »